Scientists link common immune cell to failure of checkpoint inhibitors in lung cancer

For many lung cancer patients, the best treatment options involve checkpoint inhibitors. These drugs unleash a patient’s immune system against their disease and can yield dramatic results, even in advanced cancers.

Read the full article here

Related Articles